Comparison of mometasone furoate 0.1% ointment and betamethasone dipropionate 0.05% ointment in the treatment of psoriasis vulgaris

Acta Dermatovenerologica Croatica

Volumn 8, Issue 4, 2000, Pages 223-226

  Peharda, V ^a   Gruber, F ^a   Prpic L ^a   Kastelan M ^a   Brajac, I ^a  

^a KBC RIJEKA   (Croatia)

Author keywords

Betamethasone dipropionate; Mometasone furoate; Psoriasis

Indexed keywords

BETAMETHASONE DIPROPIONATE; MOMETASONE FUROATE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PSORIASIS VULGARIS; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SKIN ATROPHY; SKIN IRRITATION; STEROID THERAPY; TREATMENT OUTCOME;

EID: 0034521820     PISSN: 1330027X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. The immunologic and genetic basis of psoriasis
2. Immunopathogenesis of psoriasis in an old concept
3. Use of corticosteroids in dermatology
4. Alcohol consumption and smoking habits in patients with psoriasis
5. The psoriasis plaque test and topical corticosteroids: Evaluation by computerized laser profilometry
6. Mometasone furoate ointment 0.1% vs. hydrocortisone ointment 1.0% in psoriasis
7. A comparative study of mometasone furoate ointment and betamethasone valerate ointment in patients with psoriasis vulgaris
8. Safety and efficacy of mometasone furoate cream in the treatment of steroid responsive dermatoses
9. Mometasone furoato a giorni al term nel trattamento della psoriasi
10. Topical corticosteroids: Experience with mometasone furoate
11. Studies in patients with corticosteroid contact allergy. Understanding cross reactivity among different steroids
12. Topical mometasone. A review of its pharmacological properties and I therapeutic use in the treatment of dermatological disorders